Neurology · Memphis, TN
NPI
1205845468
Since 2006
Specialty
Neurology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
6005 Park Ave, Suite # 722b
Memphis, TN, 38119
Phone (901) 683-8448
Groups this clinician bills Medicare through
Medicare paid, 2024
$242K
4,522 services
Medicare patients, 2024
813
Average age 74
Drug cost, 2024
$1.8M
5,378 prescriptions
Company payments, 2025
$44.9
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mohammad T Assaf was code 99232 (hospital e&m - subsequent), 1,847 times for 473 patients. In total Mohammad T Assaf billed 4,522 services in 17 codes, and Medicare paid $242K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-09-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,847 | 473 | $53.92 | $100K |
| 99231 Hospital E&M - Subsequent | Facility | 1,276 | 129 | $33.72 | $43K |
| 99213 Office E&M - Established | Office | 517 | 267 | $52.52 | $27K |
| 99222 Hospital E&M - Initial | Facility | 414 | 386 | $88.31 | $37K |
| 95816 Neurologic | Facility | 254 | 231 | $38.37 | $9,746 |
| 99223 Hospital E&M - Initial | Facility | 79 | 77 | $118.59 | $9,369 |
| 99204 Office E&M - New | Office | 71 | 71 | $100.88 | $7,162 |
| 95885 Electrical Nerve Conductivity | Office | 15 | 14 | $41.09 | $616 |
| 95816 Neurologic | Office | 15 | 15 | $235.93 | $3,539 |
By year: 2022 $240K for 4,156 services; 2023 $287K for 4,912 services; 2024 $242K for 4,522 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mohammad T Assaf prescribed most often to Medicare patients was Gabapentin, with 794 prescriptions and refills. In total Mohammad T Assaf wrote 5,378 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 794 | 877 | 163 | $11K |
| Levetiracetam Generic | 665 | 1,061 | 136 | $22K |
| Donepezil Hcl Generic | 582 | 1,049 | 175 | $3,827 |
| Topiramate Generic | 292 | 435 | 57 | $3,945 |
| Memantine Hcl Generic | 278 | 451 | 70 | $5,036 |
| Pregabalin Generic | 244 | 259 | 44 | $4,644 |
| Lacosamide Generic | 175 | 183 | 33 | $20K |
| Divalproex Sodium Generic | 167 | 214 | 28 | $4,686 |
| Primidone Generic | 131 | 251 | 40 | $1,721 |
| Amitriptyline Hcl Generic | 117 | 173 | 28 | $1,654 |
| Clonazepam Generic | 109 | 109 | 16 | $640 |
| Quetiapine Fumarate Generic | 95 | 185 | 33 | $1,004 |
| Duloxetine Hcl Generic | 89 | 133 | 23 | $1,779 |
| Clopidogrel Clopidogrel Bisulfate | 86 | 186 | 29 | $841 |
| Phenobarbital Generic | 80 | 93 | Under 11 | $1,769 |
Brand drugs: 286 claims; generic drugs: 5,011 claims; opioid claims: 15.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mohammad T Assaf $44.9 ($44.9 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbvie Inc. with $44.9.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 2 | $44.9 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.